1. Home
  2. PTY vs TMDX Comparison

PTY vs TMDX Comparison

Compare PTY & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pimco Corporate & Income Opportunity Fund

PTY

Pimco Corporate & Income Opportunity Fund

HOLD

Current Price

$12.88

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$124.15

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTY
TMDX
Founded
2002
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PTY
TMDX
Price
$12.88
$124.15
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$144.25
AVG Volume (30 Days)
550.4K
724.8K
Earning Date
01-01-0001
10-29-2025
Dividend Yield
9.65%
N/A
EPS Growth
N/A
170.70
EPS
N/A
2.54
Revenue
N/A
$566,354,000.00
Revenue This Year
N/A
$38.81
Revenue Next Year
N/A
$20.49
P/E Ratio
N/A
$48.97
Revenue Growth
N/A
41.20
52 Week Low
$11.92
$55.00
52 Week High
$14.88
$156.00

Technical Indicators

Market Signals
Indicator
PTY
TMDX
Relative Strength Index (RSI) 34.52 43.84
Support Level $12.77 $120.82
Resistance Level $12.95 $133.29
Average True Range (ATR) 0.08 5.52
MACD 0.01 -0.91
Stochastic Oscillator 27.85 19.55

Price Performance

Historical Comparison
PTY
TMDX

About PTY Pimco Corporate & Income Opportunity Fund

PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: